Kb. Kleinerman et al., USE OF ONDANSETRON FOR CONTROL OF PROJECTILE VOMITING IN PATIENTS WITH NEUROSURGICAL TRAUMA - 2 CASE-REPORTS, The Annals of pharmacotherapy, 27(5), 1993, pp. 566-568
OBJECTIVE: To describe two cases of projectile vomiting that were trea
ted successfully with ondansetron in patients with neurosurgical traum
a. Causes and pharmacologic treatments for nausea and emesis are also
discussed. DATA SOURCES: Patient data and literature citations from pu
blished case reports, review articles, and clinical research reports a
s identified by MEDLINE. DATA SYNTHESIS: Ondansetron, a potent and hig
hly selective antagonist of serotonin at the 5-HT3 (subtype 3)-recepto
r, possesses potent antiemetic effects. It has not been associated wit
h the extrapyramidal adverse effects seen with traditional antiemetics
. The occurrence of extrapyramidal reactions may limit the usefulness
of conventional antiemetics in neurosurgical patients because such age
nts interfere with serial mental status examinations and lower the sei
zure threshold. Therefore, ondansetron may be preferable in this patie
nt population. Two patients with head trauma and projectile vomiting w
ere treated successfully with ondansetron following treatment failure
with prochlorperazine. These represent the first reported cases of eff
icacious treatment with ondansetron in neurosurgical trauma patients.
CONCLUSIONS: Ondansetron may be the preferred agent for controlling na
usea and vomiting in patients with neurosurgical trauma. Controlled cl
inical trials are needed to evaluate its safety and efficacy in this p
atient population.